Cargando…
Clinical and metabolic characteristics of the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) randomised clinical trial cohort
OBJECTIVES: Diabetes Intervention Accentuating Diet and Enhancing Metabolism-I (DIADEM-I) is the first randomised controlled trial (RCT) in the Middle East and North Africa (MENA) region testing the effectiveness of an intensive lifestyle intervention (ILI) for weight loss and diabetes remission. We...
Autores principales: | Zaghloul, Hadeel, Chagoury, Odette, Elhadad, Sara, Hayder Ahmed, Salma, Suleiman, Noor, Al Naama, Abdulla, El Nahas, Katie, Al Hamaq, Abdulla, Charlson, Mary, Wells, Martin T, Al Abdulla, Samya, Abou-Samra, Abdul Badi, Taheri, Shahrad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722827/ https://www.ncbi.nlm.nih.gov/pubmed/33293319 http://dx.doi.org/10.1136/bmjopen-2020-041386 |
Ejemplares similares
-
Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial
por: Taheri, Shahrad, et al.
Publicado: (2018) -
Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission
por: Sattar, Naveed, et al.
Publicado: (2023) -
Managing diabetes in Qatar during the COVID-19 pandemic
por: Taheri, Shahrad, et al.
Publicado: (2020) -
A systematic review of randomized controlled trials of dietary interventions for weight loss in adults in the Middle East and north Africa region
por: Zaghloul, Hadeel, et al.
Publicado: (2020) -
Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol
por: Suleiman, Noor, et al.
Publicado: (2022)